Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04318717
Title Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

mucosal melanoma

Therapies

Pembrolizumab

Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.